• Monitoring healthcare legislation. Education regarding market based solutions to bring down the cost of drug prices. Education regarding the dangers of global counterfeit medications. Education regard the International Pricing Index (IPI) Model, which would import single-payer government run price controls that limit innovation and patient access to life saving therapies. Pharmacy Benefit Managers (PBM) reform including the "HELP Copays Act" - HR 830 and HR 3285 "Fairness for Patient Medications Act." HR 6283 "DRUG Act"

Duration: October 1, 2017 to present

General Issues: Health Issues, Trade (Domestic & Foreign)

Spending: about $1,080,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2017: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Office of Policy Development, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)